EC Number | Activating Compound | Comment | Organism | Structure |
---|---|---|---|---|
2.4.2.30 | 4-[[[6-cyano-1-[(1-methyl-1H-imidazol-5-yl)methyl]-1,2,3,4,6,7-hexahydroquinolin-3-yl](pyridin-2-ylsulfonyl)amino]methyl]-N,N-dimethylpiperidine-1-carboxamide | activates in presence of Mg2+, inhibits in absence of Mg2+ | Bos taurus | |
2.4.2.30 | harmaline hydrochloride | activates more strongly in absence of Mg2+ than in presence of Mg2+ | Bos taurus | |
2.4.2.30 | Phthalic acid | activates more strongly in absence of Mg2+ than in presence of Mg2+ | Bos taurus |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
2.4.2.30 | 1(2H)-phthalazinone | IC50: 0.012 mM | Bos taurus | |
2.4.2.30 | 1,2-benzopyrone | IC50: 2.8 mM | Bos taurus | |
2.4.2.30 | 1,3-benzodiazine | IC50: 2.0 mM | Bos taurus | |
2.4.2.30 | 1,3-dihydroxynaphthalene | IC50: 1.3 mM | Bos taurus | |
2.4.2.30 | 1,4-benzoquinone | IC50: 0.4 mM | Bos taurus | |
2.4.2.30 | 1,4-naphthalenedione | IC50: 0.25 mM | Bos taurus | |
2.4.2.30 | 1,5-dihydroxyisoquinoline | IC50: 0.00039 mM | Bos taurus | |
2.4.2.30 | 1,8-naphthalimide | IC50: 0.0014 mM | Bos taurus | |
2.4.2.30 | 1-hydroxy-2-methyl-4-aminonaphthalene | IC50: 1.3 mM | Bos taurus | |
2.4.2.30 | 1-hydroxyisoquinoline | IC50: 0.007 mM | Bos taurus | |
2.4.2.30 | 1-Indanone | IC50: 0.81 mM | Bos taurus | |
2.4.2.30 | 1-methylnicotinamide chloride | IC50: 3.8 mM | Bos taurus | |
2.4.2.30 | 2,3-benzodiazine | IC50: 0.15 mM | Bos taurus | |
2.4.2.30 | 2,3-dichloro-1,4-naphthoquinone | IC50: 0.26 mM | Bos taurus | |
2.4.2.30 | 2,3-dihydro-1,4-phthalazinedione | IC50: 0.03 mM | Bos taurus | |
2.4.2.30 | 2,4(1H,3H)-quinazolinedione | IC50: 0.0081 mM | Bos taurus | |
2.4.2.30 | 2,6-difluorobenzamide | IC50: 0.18 mM | Bos taurus | |
2.4.2.30 | 2-acetamidobenzamide | IC50: 1.0 mM | Bos taurus | |
2.4.2.30 | 2-amino-3-chloro-1,4-naphthoquinone | IC50: 0.82 mM | Bos taurus | |
2.4.2.30 | 2-Aminobenzamide | IC50: 0.65 mM | Bos taurus | |
2.4.2.30 | 2-bromobenzamide | IC50: 2.9 mM | Bos taurus | |
2.4.2.30 | 2-chlorobenzamide | IC50: 1.0 mM | Bos taurus | |
2.4.2.30 | 2-fluorobenzamide | IC50: 0.12 mM | Bos taurus | |
2.4.2.30 | 2-Hydroxy-1,4-naphthoquinone | IC50: 0.33 mM | Bos taurus | |
2.4.2.30 | 2-hydroxybenzamide | IC50: 0.82 mM | Bos taurus | |
2.4.2.30 | 2-mercapto-4(3H)-quinazolinone | IC50: 0.044 mM | Bos taurus | |
2.4.2.30 | 2-Methoxybenzamide | IC50: 0.2 mM | Bos taurus | |
2.4.2.30 | 2-methyl-1,4-benzopyrone | IC50: 0.045 mM | Bos taurus | |
2.4.2.30 | 2-methyl-1,4-naphthoquinone | IC50: 0.42 mM | Bos taurus | |
2.4.2.30 | 2-methyl-3-phytyl-1,4-naphthoquinone | IC50: 0.52 mM | Bos taurus | |
2.4.2.30 | 2-methyl-4(3H)-quinazolinone | IC50: 0.056 mM | Bos taurus | |
2.4.2.30 | 2-methylbenzamide | IC50: 1.5 mM | Bos taurus | |
2.4.2.30 | 2-methylchromone | IC50: 0.045 mM | Bos taurus | |
2.4.2.30 | 2-nitro-6(5H)-phenanthridione | IC50: 0.00035 mM | Bos taurus | |
2.4.2.30 | 2-phenylchromone | IC50: 0.022 mM | Bos taurus | |
2.4.2.30 | 2-trichloromethyl-4(3H)-quinazolinone | IC50: 2.2 mM | Bos taurus | |
2.4.2.30 | 2H-benz[c]isoquinolin-1-one | IC50: 0.0003 mM | Bos taurus | |
2.4.2.30 | 2H-benz[de]isoquinoline-1,3-dione | IC50: 0.0014 mM | Bos taurus | |
2.4.2.30 | 3,4-dihydro-1(2H)-naphthalenone | IC50: 0.31 mM | Bos taurus | |
2.4.2.30 | 3,5-dibromosalicylamide | IC50: 0.56 mM | Bos taurus | |
2.4.2.30 | 3,5-dimethoxybenzamide | IC50: 1.2 mM | Bos taurus | |
2.4.2.30 | 3,5-dinitrobenzamide | IC50: 2.5 mM | Bos taurus | |
2.4.2.30 | 3-(N,N-dimethylamino)benzamide | IC50: 0.12 mM | Bos taurus | |
2.4.2.30 | 3-Acetamidobenzamide | IC50: 0.012 mM | Bos taurus | |
2.4.2.30 | 3-acetamidosalicylamide | IC50: 2.0 mM | Bos taurus | |
2.4.2.30 | 3-aminobenzamide | IC50: 0.33 mM | Bos taurus | |
2.4.2.30 | 3-Aminophthalhydrazide | IC50: 0.023 mM | Bos taurus | |
2.4.2.30 | 3-bromobenzamide | IC50: 0.055 mM | Bos taurus | |
2.4.2.30 | 3-Chlorobenzamide | IC50: 0.22 mM | Bos taurus | |
2.4.2.30 | 3-Fluorobenzamide | IC50: 0.2 mM | Bos taurus | |
2.4.2.30 | 3-Hydroxybenzamide | IC50: 0.0091 mM | Bos taurus | |
2.4.2.30 | 3-Methoxybenzamide | IC50: 0.017 mM | Bos taurus | |
2.4.2.30 | 3-Methylbenzamide | IC50: 0.19 mM | Bos taurus | |
2.4.2.30 | 3-nitrobenzamide | IC50: 0.16 mM | Bos taurus | |
2.4.2.30 | 3-nitrophthalhydrazide | IC50: 0.072 mM | Bos taurus | |
2.4.2.30 | 3-nitrosalicylamide | IC50: 1.6 mM | Bos taurus | |
2.4.2.30 | 4,8-dihydroxy-2-quinolinecarboxylic acid | IC50: 0.19 mM | Bos taurus | |
2.4.2.30 | 4-amino-1,8-naphthalimide | IC50: 0.00018 mM | Bos taurus | |
2.4.2.30 | 4-Aminobenzamide | IC50: 1.8 mM | Bos taurus | |
2.4.2.30 | 4-aminophthalhydrazide | IC50: 0.29 mM | Bos taurus | |
2.4.2.30 | 4-bromobenzamide | IC50: 2.2 mM | Bos taurus | |
2.4.2.30 | 4-chlorobenzamide | IC50: 0.3 mM | Bos taurus | |
2.4.2.30 | 4-chromanone | IC50: 0.72 mM | Bos taurus | |
2.4.2.30 | 4-fluorobenzamide | IC50: 0.2 mM | Bos taurus | |
2.4.2.30 | 4-hydroxy-2-methylquinoline | IC50: 0.074 mM | Bos taurus | |
2.4.2.30 | 4-hydroxy-2-quinolinecarboxylic acid | IC50: 0.67 mM | Bos taurus | |
2.4.2.30 | 4-hydroxybenzamide | IC50: 0.28 mM | Bos taurus | |
2.4.2.30 | 4-Hydroxycoumarin | IC50: 0.57 mM | Bos taurus | |
2.4.2.30 | 4-hydroxypyridine | IC50: 2.3 mM | Bos taurus | |
2.4.2.30 | 4-hydroxyquinazoline | IC50: 0.0095 mM | Bos taurus | |
2.4.2.30 | 4-hydroxyquinoline | IC50: 0.08 mM | Bos taurus | |
2.4.2.30 | 4-methoxybenzamide | IC50: 1.1 mM | Bos taurus | |
2.4.2.30 | 4-methylbenzamide | IC50: 1.8 mM | Bos taurus | |
2.4.2.30 | 4-nitrophthalhydrazide | IC50: 0.51 mM | Bos taurus | |
2.4.2.30 | 4-[[[6-cyano-1-[(1-methyl-1H-imidazol-5-yl)methyl]-1,2,3,4,6,7-hexahydroquinolin-3-yl](pyridin-2-ylsulfonyl)amino]methyl]-N,N-dimethylpiperidine-1-carboxamide | activates in presence of Mg2+, inhibits in absence of Mg2+ | Bos taurus | |
2.4.2.30 | 5-acetamidosalicylamide | IC50: 0.045 mM | Bos taurus | |
2.4.2.30 | 5-aminosalicylamide | IC50: 0.1 mM | Bos taurus | |
2.4.2.30 | 5-Bromouracil | IC50: 0.16 mM | Bos taurus | |
2.4.2.30 | 5-Bromouridine | IC50: 0.21 mM | Bos taurus | |
2.4.2.30 | 5-chlorosalicylamide | IC50: 0.19 mM | Bos taurus | |
2.4.2.30 | 5-Chlorouracil | IC50: 0.27 mM | Bos taurus | |
2.4.2.30 | 5-hydroxy-1,4-naphthoquinone | IC50: 0.25 mM | Bos taurus | |
2.4.2.30 | 5-Hydroxy-2-methyl-1,4-naphthoquinone | IC50: 0.7 mM | Bos taurus | |
2.4.2.30 | 5-Iodouracil | IC50: 0.071 mM | Bos taurus | |
2.4.2.30 | 5-iodouridine | IC50: 0.043 mM | Bos taurus | |
2.4.2.30 | 5-Methylnicotinamide | IC50: 0.35 mM | Bos taurus | |
2.4.2.30 | 5-methyluracil | IC50: 0.29 mM | Bos taurus | |
2.4.2.30 | 5-Nitrouracil | IC50: 0.43 mM | Bos taurus | |
2.4.2.30 | 6(5H)-phenanthridinone | IC50: 0.0003 mM | Bos taurus | |
2.4.2.30 | 6-aminocoumarin | IC50: 0.85 mM | Bos taurus | |
2.4.2.30 | 6-aminonicotinamide | IC50: 1.1 mM | Bos taurus | |
2.4.2.30 | 8-acetamidocarsalam | IC50: 1.4 mM | Bos taurus | |
2.4.2.30 | acetophenone | IC50: 2.3 mM | Bos taurus | |
2.4.2.30 | all-trans-retinal | IC50: 0.45 mM | Bos taurus | |
2.4.2.30 | alpha-picolinamide | IC50: 0.25 mM | Bos taurus | |
2.4.2.30 | arachidonic acid | - |
Bos taurus | |
2.4.2.30 | Benzamide | IC50: 0.22 mM | Bos taurus | |
2.4.2.30 | benzoyleneurea | IC50: 0.0081 mM | Bos taurus | |
2.4.2.30 | carbonylsalicylamide | IC50: 0.46 mM | Bos taurus | |
2.4.2.30 | carsalam | 5 mM, 88% inhibition in presence of Mg2+, 68% inhibition in absence of Mg2+ | Bos taurus | |
2.4.2.30 | Chlorthenoxazin | IC50: 0.0085 mM | Bos taurus | |
2.4.2.30 | chromone-2-carboxylic acid | IC50: 0.56 mM | Bos taurus | |
2.4.2.30 | cyclohexanecarboxamide | IC50: 0.62 mM | Bos taurus | |
2.4.2.30 | EDTA | 5 mM, 41% inhibition in presence of Mg2+, 2% inhibition in absence of Mg2+ | Bos taurus | |
2.4.2.30 | flavone | IC50: 0.022 mM | Bos taurus | |
2.4.2.30 | gamma-linolenic acid | IC50: 0.12 mM | Bos taurus | |
2.4.2.30 | Isonicotinamide | IC50: 0.99 mM | Bos taurus | |
2.4.2.30 | Isoquinoline | 5 mM, 47% inhibition in presence of Mg2+, 34% inhibition in absence of Mg2+ | Bos taurus | |
2.4.2.30 | linoleic acid | IC50: 0.048 mM | Bos taurus | |
2.4.2.30 | linolenic acid | IC50: 0.11 mM | Bos taurus | |
2.4.2.30 | m-acetamidoacetophenone | IC50: 0.93 mM | Bos taurus | |
2.4.2.30 | m-aminoacetophenone | IC50: 1.9 mM | Bos taurus | |
2.4.2.30 | m-hydroxyacetophenone | IC50: 0.6 mM | Bos taurus | |
2.4.2.30 | m-phthalamide | IC50: 0.05 mM | Bos taurus | |
2.4.2.30 | menadione sodium bisulfite | IC50: 0.72 mM | Bos taurus | |
2.4.2.30 | N-(2-chloroethyl)1,8-naphthalamide | IC50: above 1.8 mM | Bos taurus | |
2.4.2.30 | N-hydroxynaphthalimide sodium salt | IC50: 0.45 mM | Bos taurus | |
2.4.2.30 | nicotinamide | IC50: 0.21 mM | Bos taurus | |
2.4.2.30 | norharman | IC50: 4.7 mM | Bos taurus | |
2.4.2.30 | novobiocin | IC50: 2.2 mM, 5 mM, 90% inhibition in presence of Mg2+, 59% inhibition in absence of Mg2+ | Bos taurus | |
2.4.2.30 | oleic acid | IC50: 0.082 mM | Bos taurus | |
2.4.2.30 | palmitoleic acid | IC50: 0.095 mM | Bos taurus | |
2.4.2.30 | phthalamide | IC50: 1.0 mM | Bos taurus | |
2.4.2.30 | Phthalazine | 5 mM, 91% inhibition in presence of Mg2+, 79% inhibition in absence of Mg2+ | Bos taurus | |
2.4.2.30 | Quinazoline | 5 mM, 63% inhibition in presence of Mg2+, 50% inhibition in absence of Mg2+ | Bos taurus | |
2.4.2.30 | reserpine | IC50: 0.79 mM | Bos taurus | |
2.4.2.30 | thiobenzamide | IC50: 0.62 mM | Bos taurus | |
2.4.2.30 | Thionicotinamide | IC50: 1.8 mM | Bos taurus | |
2.4.2.30 | thymidine | IC50: 0.18 mM | Bos taurus | |
2.4.2.30 | trans-decahydro-1-naphthalenone | IC50: 4.3 mM | Bos taurus | |
2.4.2.30 | vitamin K1 | IC50: 0.0019 mM | Bos taurus | |
2.4.2.30 | vitamin K3 | IC50: 0.42 mM | Bos taurus | |
2.4.2.30 | xanthurenic acid | 5 mM, 88% inhibition in presence of Mg2+, 65% inhibition in absence of Mg2+ | Bos taurus |
EC Number | Metals/Ions | Comment | Organism | Structure |
---|---|---|---|---|
2.4.2.30 | Mg2+ | activates | Bos taurus |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
2.4.2.30 | Bos taurus | - |
- |
- |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
2.4.2.30 | thymus | - |
Bos taurus | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.4.2.30 | NAD+ + (ADP-D-ribosyl)n-acceptor | - |
Bos taurus | nicotinamide + (ADP-D-ribosyl)n+1-acceptor | - |
? |
EC Number | IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|---|
2.4.2.30 | 0.00018 | - |
IC50: 0.00018 mM | Bos taurus | 4-amino-1,8-naphthalimide | |
2.4.2.30 | 0.0003 | - |
IC50: 0.0003 mM | Bos taurus | 2H-benz[c]isoquinolin-1-one | |
2.4.2.30 | 0.0003 | - |
IC50: 0.0003 mM | Bos taurus | 6(5H)-phenanthridinone | |
2.4.2.30 | 0.00035 | - |
IC50: 0.00035 mM | Bos taurus | 2-nitro-6(5H)-phenanthridione | |
2.4.2.30 | 0.00039 | - |
IC50: 0.00039 mM | Bos taurus | 1,5-dihydroxyisoquinoline | |
2.4.2.30 | 0.0014 | - |
IC50: 0.0014 mM | Bos taurus | 1,8-naphthalimide | |
2.4.2.30 | 0.0014 | - |
IC50: 0.0014 mM | Bos taurus | 2H-benz[de]isoquinoline-1,3-dione | |
2.4.2.30 | 0.0019 | - |
IC50: 0.0019 mM | Bos taurus | vitamin K1 | |
2.4.2.30 | 0.007 | - |
IC50: 0.007 mM | Bos taurus | 1-hydroxyisoquinoline | |
2.4.2.30 | 0.0081 | - |
IC50: 0.0081 mM | Bos taurus | 2,4(1H,3H)-quinazolinedione | |
2.4.2.30 | 0.0081 | - |
IC50: 0.0081 mM | Bos taurus | benzoyleneurea | |
2.4.2.30 | 0.0085 | - |
IC50: 0.0085 mM | Bos taurus | Chlorthenoxazin | |
2.4.2.30 | 0.0091 | - |
IC50: 0.0091 mM | Bos taurus | 3-Hydroxybenzamide | |
2.4.2.30 | 0.0095 | - |
IC50: 0.0095 mM | Bos taurus | 4-hydroxyquinazoline | |
2.4.2.30 | 0.012 | - |
IC50: 0.012 mM | Bos taurus | 3-Acetamidobenzamide | |
2.4.2.30 | 0.012 | - |
IC50: 0.012 mM | Bos taurus | 1(2H)-phthalazinone | |
2.4.2.30 | 0.017 | - |
IC50: 0.017 mM | Bos taurus | 3-Methoxybenzamide | |
2.4.2.30 | 0.022 | - |
IC50: 0.022 mM | Bos taurus | flavone | |
2.4.2.30 | 0.022 | - |
IC50: 0.022 mM | Bos taurus | 2-phenylchromone | |
2.4.2.30 | 0.023 | - |
IC50: 0.023 mM | Bos taurus | 3-Aminophthalhydrazide | |
2.4.2.30 | 0.03 | - |
IC50: 0.03 mM | Bos taurus | 2,3-dihydro-1,4-phthalazinedione | |
2.4.2.30 | 0.043 | - |
IC50: 0.043 mM | Bos taurus | 5-iodouridine | |
2.4.2.30 | 0.044 | - |
IC50: 0.044 mM | Bos taurus | 2-mercapto-4(3H)-quinazolinone | |
2.4.2.30 | 0.045 | - |
IC50: 0.045 mM | Bos taurus | 2-methyl-1,4-benzopyrone | |
2.4.2.30 | 0.045 | - |
IC50: 0.045 mM | Bos taurus | 2-methylchromone | |
2.4.2.30 | 0.045 | - |
IC50: 0.045 mM | Bos taurus | 5-acetamidosalicylamide | |
2.4.2.30 | 0.048 | - |
IC50: 0.048 mM | Bos taurus | linoleic acid | |
2.4.2.30 | 0.05 | - |
IC50: 0.05 mM | Bos taurus | m-phthalamide | |
2.4.2.30 | 0.055 | - |
IC50: 0.055 mM | Bos taurus | 3-bromobenzamide | |
2.4.2.30 | 0.056 | - |
IC50: 0.056 mM | Bos taurus | 2-methyl-4(3H)-quinazolinone | |
2.4.2.30 | 0.071 | - |
IC50: 0.071 mM | Bos taurus | 5-Iodouracil | |
2.4.2.30 | 0.072 | - |
IC50: 0.072 mM | Bos taurus | 3-nitrophthalhydrazide | |
2.4.2.30 | 0.074 | - |
IC50: 0.074 mM | Bos taurus | 4-hydroxy-2-methylquinoline | |
2.4.2.30 | 0.08 | - |
IC50: 0.08 mM | Bos taurus | 4-hydroxyquinoline | |
2.4.2.30 | 0.082 | - |
IC50: 0.082 mM | Bos taurus | oleic acid | |
2.4.2.30 | 0.095 | - |
IC50: 0.095 mM | Bos taurus | palmitoleic acid | |
2.4.2.30 | 0.1 | - |
IC50: 0.1 mM | Bos taurus | 5-aminosalicylamide | |
2.4.2.30 | 0.11 | - |
IC50: 0.11 mM | Bos taurus | linolenic acid | |
2.4.2.30 | 0.12 | - |
IC50: 0.12 mM | Bos taurus | gamma-linolenic acid | |
2.4.2.30 | 0.12 | - |
IC50: 0.12 mM | Bos taurus | 2-fluorobenzamide | |
2.4.2.30 | 0.12 | - |
IC50: 0.12 mM | Bos taurus | 3-(N,N-dimethylamino)benzamide | |
2.4.2.30 | 0.15 | - |
IC50: 0.15 mM | Bos taurus | 2,3-benzodiazine | |
2.4.2.30 | 0.16 | - |
IC50: 0.16 mM | Bos taurus | 5-Bromouracil | |
2.4.2.30 | 0.16 | - |
IC50: 0.16 mM | Bos taurus | 3-nitrobenzamide | |
2.4.2.30 | 0.18 | - |
IC50: 0.18 mM | Bos taurus | thymidine | |
2.4.2.30 | 0.18 | - |
IC50: 0.18 mM | Bos taurus | 2,6-difluorobenzamide | |
2.4.2.30 | 0.19 | - |
IC50: 0.19 mM | Bos taurus | 3-Methylbenzamide | |
2.4.2.30 | 0.19 | - |
IC50: 0.19 mM | Bos taurus | 4,8-dihydroxy-2-quinolinecarboxylic acid | |
2.4.2.30 | 0.19 | - |
IC50: 0.19 mM | Bos taurus | 5-chlorosalicylamide | |
2.4.2.30 | 0.2 | - |
IC50: 0.2 mM | Bos taurus | 2-Methoxybenzamide | |
2.4.2.30 | 0.2 | - |
IC50: 0.2 mM | Bos taurus | 3-Fluorobenzamide | |
2.4.2.30 | 0.2 | - |
IC50: 0.2 mM | Bos taurus | 4-fluorobenzamide | |
2.4.2.30 | 0.21 | - |
IC50: 0.21 mM | Bos taurus | nicotinamide | |
2.4.2.30 | 0.21 | - |
IC50: 0.21 mM | Bos taurus | 5-Bromouridine | |
2.4.2.30 | 0.22 | - |
IC50: 0.22 mM | Bos taurus | Benzamide | |
2.4.2.30 | 0.22 | - |
IC50: 0.22 mM | Bos taurus | 3-Chlorobenzamide | |
2.4.2.30 | 0.25 | - |
IC50: 0.25 mM | Bos taurus | 5-hydroxy-1,4-naphthoquinone | |
2.4.2.30 | 0.25 | - |
IC50: 0.25 mM | Bos taurus | 1,4-naphthalenedione | |
2.4.2.30 | 0.25 | - |
IC50: 0.25 mM | Bos taurus | alpha-picolinamide | |
2.4.2.30 | 0.26 | - |
IC50: 0.26 mM | Bos taurus | 2,3-dichloro-1,4-naphthoquinone | |
2.4.2.30 | 0.27 | - |
IC50: 0.27 mM | Bos taurus | 5-Chlorouracil | |
2.4.2.30 | 0.28 | - |
IC50: 0.28 mM | Bos taurus | 4-hydroxybenzamide | |
2.4.2.30 | 0.29 | - |
IC50: 0.29 mM | Bos taurus | 5-methyluracil | |
2.4.2.30 | 0.29 | - |
IC50: 0.29 mM | Bos taurus | 4-aminophthalhydrazide | |
2.4.2.30 | 0.3 | - |
IC50: 0.3 mM | Bos taurus | 4-chlorobenzamide | |
2.4.2.30 | 0.31 | - |
IC50: 0.31 mM | Bos taurus | 3,4-dihydro-1(2H)-naphthalenone | |
2.4.2.30 | 0.33 | - |
IC50: 0.33 mM | Bos taurus | 2-Hydroxy-1,4-naphthoquinone | |
2.4.2.30 | 0.33 | - |
IC50: 0.33 mM | Bos taurus | 3-aminobenzamide | |
2.4.2.30 | 0.35 | - |
IC50: 0.35 mM | Bos taurus | 5-Methylnicotinamide | |
2.4.2.30 | 0.4 | - |
IC50: 0.4 mM | Bos taurus | 1,4-benzoquinone | |
2.4.2.30 | 0.42 | - |
IC50: 0.42 mM | Bos taurus | 2-methyl-1,4-naphthoquinone | |
2.4.2.30 | 0.42 | - |
IC50: 0.42 mM | Bos taurus | vitamin K3 | |
2.4.2.30 | 0.43 | - |
IC50: 0.43 mM | Bos taurus | 5-Nitrouracil | |
2.4.2.30 | 0.45 | - |
IC50: 0.45 mM | Bos taurus | all-trans-retinal | |
2.4.2.30 | 0.45 | - |
IC50: 0.45 mM | Bos taurus | N-hydroxynaphthalimide sodium salt | |
2.4.2.30 | 0.46 | - |
IC50: 0.46 mM | Bos taurus | carbonylsalicylamide | |
2.4.2.30 | 0.51 | - |
IC50: 0.51 mM | Bos taurus | 4-nitrophthalhydrazide | |
2.4.2.30 | 0.52 | - |
IC50: 0.52 mM | Bos taurus | 2-methyl-3-phytyl-1,4-naphthoquinone | |
2.4.2.30 | 0.56 | - |
IC50: 0.56 mM | Bos taurus | 3,5-dibromosalicylamide | |
2.4.2.30 | 0.56 | - |
IC50: 0.56 mM | Bos taurus | chromone-2-carboxylic acid | |
2.4.2.30 | 0.57 | - |
IC50: 0.57 mM | Bos taurus | 4-Hydroxycoumarin | |
2.4.2.30 | 0.6 | - |
IC50: 0.6 mM | Bos taurus | m-hydroxyacetophenone | |
2.4.2.30 | 0.62 | - |
IC50: 0.62 mM | Bos taurus | thiobenzamide | |
2.4.2.30 | 0.62 | - |
IC50: 0.62 mM | Bos taurus | cyclohexanecarboxamide | |
2.4.2.30 | 0.65 | - |
IC50: 0.65 mM | Bos taurus | 2-Aminobenzamide | |
2.4.2.30 | 0.67 | - |
IC50: 0.67 mM | Bos taurus | 4-hydroxy-2-quinolinecarboxylic acid | |
2.4.2.30 | 0.7 | - |
IC50: 0.7 mM | Bos taurus | 5-Hydroxy-2-methyl-1,4-naphthoquinone | |
2.4.2.30 | 0.72 | - |
IC50: 0.72 mM | Bos taurus | menadione sodium bisulfite | |
2.4.2.30 | 0.72 | - |
IC50: 0.72 mM | Bos taurus | 4-chromanone | |
2.4.2.30 | 0.79 | - |
IC50: 0.79 mM | Bos taurus | reserpine | |
2.4.2.30 | 0.81 | - |
IC50: 0.81 mM | Bos taurus | 1-Indanone | |
2.4.2.30 | 0.82 | - |
IC50: 0.82 mM | Bos taurus | 2-hydroxybenzamide | |
2.4.2.30 | 0.82 | - |
IC50: 0.82 mM | Bos taurus | 2-amino-3-chloro-1,4-naphthoquinone | |
2.4.2.30 | 0.85 | - |
IC50: 0.85 mM | Bos taurus | 6-aminocoumarin | |
2.4.2.30 | 0.93 | - |
IC50: 0.93 mM | Bos taurus | m-acetamidoacetophenone | |
2.4.2.30 | 0.99 | - |
IC50: 0.99 mM | Bos taurus | Isonicotinamide | |
2.4.2.30 | 1 | - |
IC50: 1.0 mM | Bos taurus | 2-chlorobenzamide | |
2.4.2.30 | 1 | - |
IC50: 1.0 mM | Bos taurus | 2-acetamidobenzamide | |
2.4.2.30 | 1 | - |
IC50: 1.0 mM | Bos taurus | phthalamide | |
2.4.2.30 | 1.1 | - |
IC50: 1.1 mM | Bos taurus | 6-aminonicotinamide | |
2.4.2.30 | 1.1 | - |
IC50: 1.1 mM | Bos taurus | 4-methoxybenzamide | |
2.4.2.30 | 1.2 | - |
IC50: 1.2 mM | Bos taurus | 3,5-dimethoxybenzamide | |
2.4.2.30 | 1.3 | - |
IC50: 1.3 mM | Bos taurus | 1,3-dihydroxynaphthalene | |
2.4.2.30 | 1.3 | - |
IC50: 1.3 mM | Bos taurus | 1-hydroxy-2-methyl-4-aminonaphthalene | |
2.4.2.30 | 1.4 | - |
IC50: 1.4 mM | Bos taurus | 8-acetamidocarsalam | |
2.4.2.30 | 1.5 | - |
IC50: 1.5 mM | Bos taurus | 2-methylbenzamide | |
2.4.2.30 | 1.6 | - |
IC50: 1.6 mM | Bos taurus | 3-nitrosalicylamide | |
2.4.2.30 | 1.8 | - |
IC50: 1.8 mM | Bos taurus | Thionicotinamide | |
2.4.2.30 | 1.8 | - |
IC50: 1.8 mM | Bos taurus | 4-Aminobenzamide | |
2.4.2.30 | 1.8 | - |
IC50: 1.8 mM | Bos taurus | 4-methylbenzamide | |
2.4.2.30 | 1.8 | - |
IC50: above 1.8 mM | Bos taurus | N-(2-chloroethyl)1,8-naphthalamide | |
2.4.2.30 | 1.9 | - |
IC50: 1.9 mM | Bos taurus | m-aminoacetophenone | |
2.4.2.30 | 2 | - |
IC50: 2.0 mM | Bos taurus | 1,3-benzodiazine | |
2.4.2.30 | 2 | - |
IC50: 2.0 mM | Bos taurus | 3-acetamidosalicylamide | |
2.4.2.30 | 2.2 | - |
IC50: 2.2 mM | Bos taurus | 4-bromobenzamide | |
2.4.2.30 | 2.2 | - |
IC50: 2.2 mM | Bos taurus | 2-trichloromethyl-4(3H)-quinazolinone | |
2.4.2.30 | 2.2 | - |
IC50: 2.2 mM, 5 mM, 90% inhibition in presence of Mg2+, 59% inhibition in absence of Mg2+ | Bos taurus | novobiocin | |
2.4.2.30 | 2.3 | - |
IC50: 2.3 mM | Bos taurus | acetophenone | |
2.4.2.30 | 2.3 | - |
IC50: 2.3 mM | Bos taurus | 4-hydroxypyridine | |
2.4.2.30 | 2.5 | - |
IC50: 2.5 mM | Bos taurus | 3,5-dinitrobenzamide | |
2.4.2.30 | 2.8 | - |
IC50: 2.8 mM | Bos taurus | 1,2-benzopyrone | |
2.4.2.30 | 2.9 | - |
IC50: 2.9 mM | Bos taurus | 2-bromobenzamide | |
2.4.2.30 | 3.8 | - |
IC50: 3.8 mM | Bos taurus | 1-methylnicotinamide chloride | |
2.4.2.30 | 4.3 | - |
IC50: 4.3 mM | Bos taurus | trans-decahydro-1-naphthalenone | |
2.4.2.30 | 4.7 | - |
IC50: 4.7 mM | Bos taurus | norharman |